IP Library Granted Patent US 11,412,963
Granted Patent B2
US 11,412,963 · App. 17/035,751 · Granted Aug 16, 2022

Method for measuring concentration of substance in blood

Inventor: Koichi Yamakawa (Kyoto, JP)
Assignee: National Institutes for Quantum Science and Technology
A61B5/1455A61B5/14532A61B5/14546G01N21/55G02F1/3501G02F1/39A61B2090/306A61B2090/3614A61B2562/0233G02F1/3507H01S3/1603H01S3/1643H01S3/2232
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,412,963
App. No.
17/035,751
Granted
Aug 16, 2022
Kind
B2
Abstract

The concentration of substance in blood is measured non-invasively, with high accuracy and with simple configuration. Laser light generated by a light source is locally irradiated on the body epithelium of a subject, and the resulting diffused reflected light is detected by a light detector. The laser light has a wavelength of 9.26 μm. The laser light is generated by converting and amplifying pulsed excitation light from an excitation light source to a long wavelength. A plate-shaped window that is transparent to mid-infrared light is brought in close contact with the body epithelium. The glucose concentration in interstitial fluid can be calculated using normalized light intensity calculated from a signal ratio of signals from a monitoring light detector and the light detector.

Claims (23)

1. A method for measuring a concentration of substance, comprising the steps of

(i) irradiating a body with a first laser light having a wavelength within the range 2.5 μm to 12 μm and that is absorbed by the substance,

(ii) detecting light intensity of first diffused reflected light that is generated by the step of irradiating the body with the first laser light, and

(iii) measuring the concentration of the substance in epithelial interstitial fluid of the body by the detected light intensity,

in the step (i), the first laser light being guided to the body by an incident-side optical waveguide,

in the step (ii), the first diffused reflected light being guided by an exit-side optical waveguide to a light-detection unit for detecting the light intensity,

the incident-side optical waveguide and the exit-side optical waveguide being provided in a light-guiding unit, and

on a cross section of the light-guiding unit, the incident-side optical waveguide and the exit-side optical waveguide being provided to form a substantially V shape.

2. The method for measuring the concentration of substance according to claim 1 , wherein

in the step (i), the first laser light is guided to the body at an incident angle of 35° to 85°.

3. The method for measuring the concentration of substance according to claim 1 , wherein

in the step (i), the first laser light is oscillated by optical parametric oscillation.

4. The method for measuring the concentration of substance according to claim 1 , wherein

in the step (i), the first laser light is oscillated by a carbon dioxide gas laser oscillator.

5. The method for measuring the concentration of substance according to claim 1 , wherein

in the step (i), the body is irradiated with a second laser light having a wavelength that is within the range 2.5 μm to 12 μm and having a characteristic of being absorbed by the substance less than the first laser light, and

in the step (iii), the concentration of the substance in epithelial interstitial fluid of the body is measured by the light intensity of the first diffused reflected light and light intensity of second diffused reflected light that is generated by the second laser light.

6. The method for measuring the concentration of substance according to claim 5 , wherein

in the step (i), an optical path of the first laser light and an optical path of the second laser light overlap, and

in the step (iii), an optical path of the first diffused reflected light that is incident on the light-detection unit that detects the light intensity, and an optical path of the second diffused reflected light that is incident on the light-detection unit overlap.

7. The method for measuring the concentration of substance according to claim 1 , wherein

the substance is glucose, and

in the step (i), the wavelength of the first laser light is within the range 7.0 μm to 11 μm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2022
From: YAMAKAWA, KOICHI
To: NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY
Reel/Frame 060143/0752 →
CHANGE OF NAME Recorded Jun 9, 2022
From: NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY
To: NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY
Reel/Frame 060143/0758 →
Priority Claims (1)
JP 2015-009504 · Jan 21, 2015 · national
Continuity (2)
Division 15545661
Related Publication 20210038125A1 · Feb 11, 2021